| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 0 | 52.520 | 61.844 | 245.234 |
| Total Income - EUR | - | - | - | 0 | 0 | 0 | 112.944 | 62.969 | 7.125 | 180.390 |
| Total Expenses - EUR | - | - | - | 2.839 | 3.059 | 2.574 | 117.439 | 88.507 | 141.470 | 139.952 |
| Gross Profit/Loss - EUR | - | - | - | -2.839 | -3.059 | -2.574 | -4.495 | -25.537 | -134.345 | 40.438 |
| Net Profit/Loss - EUR | - | - | - | -2.839 | -3.059 | -2.574 | -4.495 | -27.113 | -134.345 | 33.470 |
| Employees | - | - | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Melissen Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 551.138 | 549.250 | 447.051 |
| Current Assets | - | - | - | 118 | 501 | 111.344 | 1.226.529 | 1.136.878 | 204.713 | 132.604 |
| Inventories | - | - | - | 0 | 0 | 110.437 | 1.212.960 | 1.182.052 | 71.385 | 2.948 |
| Receivables | - | - | - | 34 | 401 | 744 | 13.477 | -45.185 | 133.187 | 125.831 |
| Cash | - | - | - | 84 | 99 | 162 | 92 | 11 | 141 | 3.825 |
| Shareholders Funds | - | - | - | -2.796 | -5.790 | -8.244 | -10.939 | -38.086 | -176.995 | -142.395 |
| Social Capital | - | - | - | 43 | 53 | 62 | 61 | 61 | 61 | 201 |
| Debts | - | - | - | 2.914 | 6.291 | 119.588 | 1.237.469 | 1.726.101 | 930.958 | 722.050 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4211
|
|||||||||
Comments - Melissen Medical S.r.l.